In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk

Key Points

• To evaluate the effectiveness and tolerability of atomoxetine, methylphenidate, and cognitive behavioral therapy (CBT) in adults with ADHD.
• Evaluated the effects of atomoxetine, methylphenidate, and CBT over 12 weeks.
• Compared these treatments to a control group.
• Assessed symptom severity and treatment tolerability.
• All interventions significantly reduced symptom severity compared to control.
• Atomoxetine and methylphenidate had lower tolerability than control.
• CBT showed favorable effects on reducing symptoms.

Abstract